Researchers have developed an animal model to test HIV infection and therapies in infants, allowing them to develop biomarkers to predict viral rebound after antiretroviral therapy (ART) interruption. The simian-human immunodeficiency virus (SHIV)-infected infant rhesus macaque model is a collaborative effort among researchers at several institutions.